echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: A review of cerebral cavernous malformations, a comparison of treatments

    JNNP: A review of cerebral cavernous malformations, a comparison of treatments

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cavernous malformations (CMs) are dilated blood vessels with a typical mulberry-like appearance that occur in veno-capillaries without interfering with brain parenchyma, muscle, or elastic tissue
    .


    According to the latest International Society for the Study of Hemangioma (ISSVA) classification of vascular abnormalities, CMs are defined as slow-flow venous malformations


    The meta-analysis was performed to unify the results of all possible treatment regimens, clarify their efficacy, and specify factors associated with the dynamic behavior of CCMs


    PubMed, Cochrane Library, Science Direct, ISI Web of Science, Embase and other sources were searched to identify cohort studies published between 1990 and 2020 on the treatment of CCMs
    .


    Preferred reporting item following guidelines for systematic reviews and meta-analyses; the Newcastle-Ottawa scale was used to assess risk of bias and limitations were assessed based on selection/outcome bias


    Assess risk factors for poor treatment outcomes


    Efficacy and mortality/mortality for each treatment

    During the follow-up of 41,098 people, a total of 100 cohorts were analyzed, of which 8,994 patients were treated with CCMs
    .


    Effectiveness in ensuring bleeding prevention was 97% in surgery, 86% in radiosurgery, and 77% in conservative management


    During the follow-up of 41,098 people, a total of 100 cohorts were analyzed, of which 8,994 patients were treated with CCMs


    Post-treatment bleeding rates in radiosurgery, association with patients, and study characteristics

    Surgery is usually considered first-line treatment
    .


    Surgical intervention may be considered in patients with a history of two or more hemorrhages, neurological deficits, or uncontrolled epilepsy, based on long-term accepted thresholds


    Surgery is usually considered first-line treatment


    BubenikovaA ,SkalickyP ,Benes JrV , et al Overview of cerebral cavernous malformations: comparison of treatment approaches Journal of Neurology, Neurosurgery & PsychiatryPublished Online First:10 March 2022.


    BubenikovaA ,SkalickyP ,Benes Jr  V Bubenikova  ABubenikova Skalicky  PSkalicky Benes Jr  VBenes Jr, et al Overview of cerebral cavernous malformations: comparison of treatment approaches Overview of cerebral cavernous malformations: comparison of treatment approachesJournal of Neurology, Neurosurgery & Psychiatry  Published Online First:  10 March 2022.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.